The "in vitro" effect of IFN-alpha on the phenotypic profile of atypical cells from 5 hairy cell leukemia patients was investigated in a 72 hr culture assay. Cytochemical investigations revealed a dramatic decrease in the cytoplasmic content of acid phosphatase and tartrate resistant acid phosphatase in the absence of any apparent morphological modification. Flow cytometry showed that IFN-alpha markedly reduced the density of surface Ig without modifying the original isotype pattern. The expression of the receptor for the Fc fragment of IgG was also reduced. The class II MHC antigen recognized by the monoclonal antibody 12 remained essentially unchanged. Hairy cells were negative for OKT10 and PCA-1 and remained so after IFN-alpha incubatio...
In this study in vitro results obtained with hu rec IFN-alpha 2b on Ph1+ stem cells from patients wi...
Culture studies of peripheral blood mononuclear cells from 7 entirely typical cases of hairy cell le...
Twenty-five patients with Hairy Cell Leukemia (HCL), eleven in post-splenectomy progressive disease,...
To investigate the possible direct effects of alpha-interferon (IFN-alpha) in hairy cell leukemia, I...
Hairy cells (HCs), derived from the peripheral blood and spleen of hairy cell leukemia (HCL) patient...
This paper reports the bone marrow histological picture in 7 patients with hairy cell leukemia treat...
The in vitro effect of beta- and alpha-IFN on NK activity has been evaluated in 10 patients with Hai...
To further define the mechanisms responsible for the alpha-interferon (alpha-IFN) efficacy in the tr...
the effect of alpha interferon on the immune has been investigated in vitro in HCL patient
To elucidate the mechanisms of alpha-interferon's (alpha-INF) therapeutic effect on clinical and lab...
To elucidate the mechanisms of alpha-interferon's (alpha-INF) therapeutic effect on clinical and lab...
Although hairy cell leukemia is uniquely sensitive to interferon- (IFN-), the biologic basis for th...
During the past 6 years, clinical trials employing alpha-interferon (alpha-IFN) in hairy cell leukem...
To investigate the possible direct effects of interferon-α (IFN-α) in hairy-cell leukaemia, IFN-α re...
Ten patients with hairy cell leukemia are being treated at our institution with a therapeutic schedu...
In this study in vitro results obtained with hu rec IFN-alpha 2b on Ph1+ stem cells from patients wi...
Culture studies of peripheral blood mononuclear cells from 7 entirely typical cases of hairy cell le...
Twenty-five patients with Hairy Cell Leukemia (HCL), eleven in post-splenectomy progressive disease,...
To investigate the possible direct effects of alpha-interferon (IFN-alpha) in hairy cell leukemia, I...
Hairy cells (HCs), derived from the peripheral blood and spleen of hairy cell leukemia (HCL) patient...
This paper reports the bone marrow histological picture in 7 patients with hairy cell leukemia treat...
The in vitro effect of beta- and alpha-IFN on NK activity has been evaluated in 10 patients with Hai...
To further define the mechanisms responsible for the alpha-interferon (alpha-IFN) efficacy in the tr...
the effect of alpha interferon on the immune has been investigated in vitro in HCL patient
To elucidate the mechanisms of alpha-interferon's (alpha-INF) therapeutic effect on clinical and lab...
To elucidate the mechanisms of alpha-interferon's (alpha-INF) therapeutic effect on clinical and lab...
Although hairy cell leukemia is uniquely sensitive to interferon- (IFN-), the biologic basis for th...
During the past 6 years, clinical trials employing alpha-interferon (alpha-IFN) in hairy cell leukem...
To investigate the possible direct effects of interferon-α (IFN-α) in hairy-cell leukaemia, IFN-α re...
Ten patients with hairy cell leukemia are being treated at our institution with a therapeutic schedu...
In this study in vitro results obtained with hu rec IFN-alpha 2b on Ph1+ stem cells from patients wi...
Culture studies of peripheral blood mononuclear cells from 7 entirely typical cases of hairy cell le...
Twenty-five patients with Hairy Cell Leukemia (HCL), eleven in post-splenectomy progressive disease,...